stockrow
Friday 6 November 2026
Export ANGO’s income statement to Excel — free account
AngioDynamics, Inc.
ANGO Healthcare Medical Instruments & Supplies
AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025.
- Revenue
- +6.87%
- EPS
- +34.6%
- Free cash flow
- +5.62%
Quarter to August 2026, against a year earlier
11.69
0.12
−1.02%
Follow ANGO
Alert me
| Older periods | Nov '25 | Feb '26 | May '26 | Aug '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 6 |
| (15.26%) | (17.47%) | (20.77%) | (19.21%) | ||
| (9.87%) | (11.50%) | (13.43%) | (12.98%) | ||
ROIC |
(15.10%) | (16.38%) | (21.34%) | (17.58%) | |
Return on Tangible Assets |
(23.11%) | (26.46%) | (31.74%) | (29.66%) | |
Average Days of Receivables |
52.78 | 53.00 | 55.09 | 50.37 | |
Free Cash Flow per Share |
(0.22) | 0.04 | 0.01 | 0.03 | |
Free Cash Flow |
(9.33) | 1.50 | 0.51 | 1.44 | |
Capital Expenditures |
(3.73) | (2.94) | (2.58) | (2.23) | |
| Other line items | |||||
Cash ROIC |
(4.28%) | 0.71% | 0.23% | 0.73% | |
Accounts Receivable Turnover |
7.02 | 6.64 | 7.02 | 7.43 | |
Accounts Payable Turnover |
3.98 | 4.83 | 4.48 | 4.94 | |
Inventory Turnover |
2.12 | 2.36 | 2.54 | 2.46 | |
Average Days of Payables |
92.54 | 74.09 | 79.17 | 67.23 | |
Days of Inventory on Hand |
171.45 | 149.11 | 131.74 | 139.00 | |
Tax Rate |
0.00 | 0.00 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
9.01% | 8.88% | 9.20% | 9.53% | |
Selling, General and Administrative Expense of Revenue |
48.88% | 48.57% | 49.06% | 48.82% | |
Share Based Compensation of Revenue |
3.71% | 3.72% | 4.36% | 4.30% | |
Interest Coverage |
— | — | (443.63) | 5,224.71 | |
Operating CF/Net income |
0.20 | (0.14) | (0.08) | (0.11) | |
Depreciation/Fixed assets |
0.78 | 0.80 | 0.85 | 0.81 | |
Capex/Depreciation |
(0.16) | (0.13) | (0.11) | (0.10) | |
Revenue per Share |
7.40 | 7.54 | 7.71 | 7.74 | |
Operating CF per Share |
(0.13) | 0.11 | 0.07 | 0.09 | |
Capex per Share |
(0.09) | (0.07) | (0.06) | (0.05) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026